Cargando…

A Gender Factor in Shaping T-Cell Immunity to Melanoma

Detalles Bibliográficos
Autores principales:	Dronca, Roxana S., Dong, Haidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313609/ https://www.ncbi.nlm.nih.gov/pubmed/25699234 http://dx.doi.org/10.3389/fonc.2015.00008

Ejemplares similares

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Paradox-driven adventures in the development of cancer immunology and immunotherapy
por: Barham, Whitney, et al.
Publicado: (2019)

Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017)

ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies
por: Chen, Jingyu, et al.
Publicado: (2020)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy
por: Davidson, Tara M, et al.
Publicado: (2022)

Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
por: Tucci, Marco, et al.
Publicado: (2019)

Single cell metabolic imaging of tumor and immune cells in vivo in melanoma bearing mice
por: Heaton, Alexa R., et al.
Publicado: (2023)

Development of an Immune-Related Gene Signature for Prognosis in Melanoma
por: Zhang, Jia-An, et al.
Publicado: (2021)

The immune-related role of beta-2-microglobulin in melanoma
por: Wang, Chuqiao, et al.
Publicado: (2022)

ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023)

Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration
por: Degan, Simone, et al.
Publicado: (2022)

G protein-coupled receptor GPR68 inhibits lymphocyte infiltration and contributes to gender-dependent melanoma growth
por: Ye, Shangmei, et al.
Publicado: (2023)

Macrophage and T-Cell Infiltration and Topographic Immune Cell Distribution in Non-Melanoma Skin Cancer of the Head and Neck
por: Frohwitter, Gesche, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review
por: Zheng, Qingyue, et al.
Publicado: (2020)

DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma
por: Xue, Wenli, et al.
Publicado: (2022)

Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review
por: Jessurun, Charissa A. C., et al.
Publicado: (2017)

Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
por: Jallad, Mary-Ann N., et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan
por: Wu, Chiao-En, et al.
Publicado: (2020)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
por: Johansson, Junko, et al.
Publicado: (2018)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Identification of Genes Related to Immune Infiltration in the Tumor Microenvironment of Cutaneous Melanoma
por: Qin, Rujia, et al.
Publicado: (2021)

Exploring Tumor Immune Microenvironment and Its Associations With Molecular Characteristics in Melanoma
por: Wang, Jiangyuan, et al.
Publicado: (2022)

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
por: Vera Aguilera, Jesus, et al.
Publicado: (2020)

Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
por: Yang, Junbao, et al.
Publicado: (2017)

Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients
por: Li, Gang, et al.
Publicado: (2021)

Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence
por: Stonesifer, Connor J., et al.
Publicado: (2021)

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma
por: Song, Binyu, et al.
Publicado: (2022)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
por: Lin, Zhen, et al.
Publicado: (2020)

Operative management of immune checkpoint colitis following in-transit melanoma: Case report
por: Childers, Betzaira G., et al.
Publicado: (2023)

Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023)

A Model of Dendritic Cell Therapy for Melanoma
por: DePillis, Lisette, et al.
Publicado: (2013)

Circulating Melanoma Cells: Scoping the Target
por: Joshi, Powrnima, et al.
Publicado: (2013)

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data
por: Ott, Patrick A., et al.
Publicado: (2015)

Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors
por: Usui, Yoshihiko, et al.
Publicado: (2016)

Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer
por: Jia, Xiaolong, et al.
Publicado: (2023)

De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma
por: Ma, Si-Cong, et al.
Publicado: (2021)

Risk of Pneumonitis Associated With Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Network Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4q23a7ejc67f7tvo79o8s673jp